G. N. Gorokhovskaya
Research Subjects
G. N. Gorokhovskaya has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Anatoliy I. Martynov
Russian University of Medicine
3 shared publications - V. L. Yun
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
3 shared publications - M. M. Petina
MEDSI Clinical Diagnostic Center
2 shared publications - S. V. Moiseyenko
Central Clinical Hospital with Outpatient Health Center
2 shared publications - Yuri A. Vasyuk
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
2 shared publications Ю. А. Васюк
Московский государственный медико-стоматологический университет им. А.И. Евдокимова
2 shared publications
Latest Publications
- Open Access
- 15 October 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 14,p. 70-78
The modern view of general practitioner on the problem of iron deficiency anemia in patients with cardiovascular pathology
Современный взгляд терапевта на проблему железодефицитной анемии у пациентов с сердечно-сосудистой патологией
- 15 October 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 14,p. 70-78
Open AccessThe modern view of general practitioner on the problem of iron deficiency anemia in patients with cardiovascular pathology
Современный взгляд терапевта на проблему железодефицитной анемии у пациентов с сердечно-сосудистой патологией
- Open Access
- 22 May 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 4,p. 22-28
Relationship of type 2 diabetes mellitus and cardiovascular pathology: significance of glycemic control on the way to solving the problem
Взаимосвязь сахарного диабета 2-го типа и сердечно-сосудистой патологии: значение контроля гликемии на пути решения проблемы
- 22 May 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 4,p. 22-28
Open AccessRelationship of type 2 diabetes mellitus and cardiovascular pathology: significance of glycemic control on the way to solving the problem
Взаимосвязь сахарного диабета 2-го типа и сердечно-сосудистой патологии: значение контроля гликемии на пути решения проблемы
- Open Access
- 9 October 2019
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 16,p. 10-18
Current perspectives on fixed-dose ACE inhibitordiuretic combination therapy in the management of arterial hypertension
Despite our achievements in modern medicine, arterial hypertension (AH) remains one of the main causes of fatal complications, such as myocardial infarction and acute cerebrovascular accident leading to disability and mortality of patients, including those of working age. The prevalence of hypertension is significantly higher among old and senile age population, however, it has recently tended to increase in young and middle-aged people. Thus, the Russian epidemiological ESSE-RF study, in which representative sample of the Russian population aged 25–64 years were studied, showed that the prevalence of hypertension in individuals of that age group was 44%. It was predicted that the world’s burden of hypertension would increase by 15–20% to approximately 1.5 million people in the year 2015. Due to the high incidence of hypertension and complications associated with hypertension development, further study of pathogenetic mechanisms, development of diagnostic examination methods, prophylactic measures and the search for new treatment options with fixed-dose combination drugs is an important area of modern medicine. This article provides an overview of clinical studies of the components (lisinopril and indapamide) of a rational ACE inhibitor–diuretic combination and a clinical example.
- 9 October 2019
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 16,p. 10-18
Open AccessCurrent perspectives on fixed-dose ACE inhibitordiuretic combination therapy in the management of arterial hypertension
Despite our achievements in modern medicine, arterial hypertension (AH) remains one of the main causes of fatal complications, such as myocardial infarction and acute cerebrovascular accident leading to disability and mortality of patients, including those of working age. The prevalence of hypertension is significantly higher among old and senile age population, however, it has recently tended to increase in young and middle-aged people. Thus, the Russian epidemiological ESSE-RF study, in which representative sample of the Russian population aged 25–64 years were studied, showed that the prevalence of hypertension in individuals of that age group was 44%. It was predicted that the world’s burden of hypertension would increase by 15–20% to approximately 1.5 million people in the year 2015. Due to the high incidence of hypertension and complications associated with hypertension development, further study of pathogenetic mechanisms, development of diagnostic examination methods, prophylactic measures and the search for new treatment options with fixed-dose combination drugs is an important area of modern medicine. This article provides an overview of clinical studies of the components (lisinopril and indapamide) of a rational ACE inhibitor–diuretic combination and a clinical example.
- Open Access
- 1 January 2018
- Published by Consilium Medicum in Consilium Medicum
- Vol. 20 (12) , 61-68
Modern opportunities of nitropreparations in patients with ischemic heart disease: from angina to polymorbidity
Nitrates are still widely used in treatment of different types of ischemic heart disease. The trend to reduction of prolonged di- and mononitrate forms use that is coming from new antianginal medications development cannot be considered justified. In both outpatient and hospital practice, it is impossible to abandon the use of the positive properties of these medicines in the combined treatment of cardiac diseases. Along with nitrates, effect of metabolic cytoprotection use in complex treatment was proven to be statistically significant in a number of studies. It results in decreased length of hospital stay, angina frequency, and nitrate use reduction as well as in patients’ exercise tolerance increase, disease course modification, and disease prognosis improvement. Key words: nitrates, ischemic heart disease, polymorbidity, metabolic support, meldonium, Mildronate. For citation: Gorokhovskaya G.N., Vasyuk Yu.A., Martynov A.I. et al. Modern opportunities of nitropreparations in patients with ischemic heart disease: from angina to polymorbidity. Consilium Medicum. 2018; 20 (12): 61–68. DOI: 10.26442/20751753.2018.12.180063
- 1 January 2018
- Published by Consilium Medicum in Consilium Medicum
- Vol. 20 (12) , 61-68
Open AccessModern opportunities of nitropreparations in patients with ischemic heart disease: from angina to polymorbidity
Nitrates are still widely used in treatment of different types of ischemic heart disease. The trend to reduction of prolonged di- and mononitrate forms use that is coming from new antianginal medications development cannot be considered justified. In both outpatient and hospital practice, it is impossible to abandon the use of the positive properties of these medicines in the combined treatment of cardiac diseases. Along with nitrates, effect of metabolic cytoprotection use in complex treatment was proven to be statistically significant in a number of studies. It results in decreased length of hospital stay, angina frequency, and nitrate use reduction as well as in patients’ exercise tolerance increase, disease course modification, and disease prognosis improvement. Key words: nitrates, ischemic heart disease, polymorbidity, metabolic support, meldonium, Mildronate. For citation: Gorokhovskaya G.N., Vasyuk Yu.A., Martynov A.I. et al. Modern opportunities of nitropreparations in patients with ischemic heart disease: from angina to polymorbidity. Consilium Medicum. 2018; 20 (12): 61–68. DOI: 10.26442/20751753.2018.12.180063